Evaluation of Serum Cotinine Cut-Off to Distinguish Smokers From Nonsmokers in the Korean Population

다국어 초록 (Multilingual Abstract)

Background: Cotinine has been widely used as an objective marker to identify current smokers. We conducted this study to address the absence of Korean studies investigating the efficacy of immunoassays and liquid chromatography–tandem mass spectrometry (LC-MS/MS) for the detection of serum cotinine and to determine the optimal serum cotinine cut-off level for differentiating current smokers from nonsmokers.
Methods: Serum specimens were obtained from 120 subjects. They were randomly chosen to represent a broad distribution of urine cotinine levels based on a retrospective review of questionnaires and results of urine cotinine levels. We determined serum cotinine levels using the IMMULITE 2000 XPi Immunoassay System (Siemens Healthcare Diagnostics Inc., USA) and LC-MS/MS (API-4000, Applied Biosystems, USA). Correlation was analyzed between IMMULITE serum cotinine, urine cotinine, and LC-MS/MS serum cotinine levels. ROC curve was analyzed to identify the optimal IMMULITE serum cotinine cut-off level for differentiating current smokers from nonsmokers.
Results: IMMULITE serum cotinine levels correlated with both urine cotinine and LC-MS/MS serum cotinine levels, with correlation coefficients of 0.958 and 0.986, respectively. The optimal serum cotinine cut-off level for distinguishing current smokers from nonsmokers was 13.2 ng/mL (95.7% sensitivity, 94.1% specificity) using IMMULITE.
Conclusions: This is the first study to investigate the use of LC-MS/MS for the measurement of serum cotinine and to determine the optimal serum cotinine cut-off level for the IMMULITE immunoassay. Our results could provide guidelines for differentiating current smokers from nonsmokers in the Korean population.

참고문헌 (Reference)

1 강윤희, "흡연자 선별을 위한 요중 코티닌 검사의 유용성" 대한진단검사의학회 23 (23): 92-97, 2003

2 이소룡, "부산, 울산 및 경남지역의 간접흡연 노출에 의한 직업군별 요중 코티닌 농도" 대한직업환경의학회 23 (23): 42-52, 2011

3 김정유, "보건소 금연클리닉의 금연치료 결과에 대한 자가보고와 요중 코티닌 검사 간의 일치도" 대한정신약물학회 21 (21): 210-215, 2010

4 Agaku IT, "Validation of self-reported smokeless tobacco use by measurement of serum cotinine concentration among US adults" 180 : 749-754, 2014

5 정성모, "Urine Cotinine for Assessing Tobacco Smoke Exposure in Korean: Analysis of the Korea National Health and Nutrition Examination Survey (KNHANES)" 대한결핵및호흡기학회 73 (73): 210-218, 2012

6 Haufroid V, "Urinary cotinine as a tobacco-smoke exposure index: a minireview" 71 : 162-168, 1998

7 Wei B, "Urinary concentrations of PAH and VOC metabolites in marijuana users" 88 : 1-8, 2015

8 Pirkle JL, "Trends in the exposure of nonsmokers in the U.S. population to secondhand smoke: 1988-2002" 114 : 853-858, 2006

9 Binnie V, "The validation of self-reported smoking status by analysing cotinine levels in stimulated and unstimulated saliva, serum and urine" 10 : 287-293, 2004

10 Caraballo RS, "Self-reported cigarette smoking vs. serum cotinine among U.S. adolescents" 6 : 19-25, 2004

11 전형준, "Self-reported Smoking and Urinary Cotinine Levels among Pregnant Women in Korea and Factors Associated with Smoking during Pregnancy" 대한의학회 25 (25): 752-757, 2010

12 Yamazaki H, "Roles of CYP2A6 and CYP2B6 in nicotine C-oxidation by human liver microsomes" 73 : 65-70, 1999

13 Florescu A, "Reference values for hair cotinine as a biomarker of active and passive smoking in women of reproductive age, pregnant women, children, and neonates: systematic review and meta-analysis" 29 : 437-446, 2007

14 Signorello LB, "Racial differences in serum cotinine levels of smokers" 27 : 187-192, 2009

15 Wagenknecht LE, "Racial differences in serum cotinine levels among smokers in the Coronary Artery Risk Development in (Young) Adults study" 80 : 1053-1056, 1990

16 Caraballo RS, "Racial and ethnic differences in serum cotinine levels of cigarette smokers: Third National Health and Nutrition Examination Survey, 1988-1991" 280 : 135-139, 1998

17 Stead LF, "Physician advice for smoking cessation" CD000165-, 2008

18 Benowitz NL, "Optimal serum cotinine levels for distinguishing cigarette smokers and nonsmokers within different racial/ethnic groups in the United States between 1999 and 2004" 169 : 236-248, 2009

19 Kwon JT, "Nicotine metabolism and CYP2A6 allele frequencies in Koreans" 11 : 317-323, 2001

20 Benowitz NL, "Nicotine and cotinine elimination pharmacokinetics in smokers and nonsmokers" 53 : 316-323, 1993

21 Yang M, "Individual differences in urinary cotinine levels in Japanese smokers: relation to genetic polymorphism of drug-metabolizing enzymes" 10 : 589-593, 2001

22 Fielding JE, "Health effects of involuntary smoking" 319 : 1452-1460, 1988

23 Tzatzarakis MN, "Hair nicotine/cotinine concentrations as a method of monitoring exposure to tobacco smoke among infants and adults" 31 : 258-265, 2012

24 Caraballo RS, "Factors associated with discrepancies between self-reports on cigarette smoking and measured serum cotinine levels among persons aged 17 years or older: Third National Health and Nutrition Examination Survey, 1988-1994" 153 : 807-814, 2001

25 Pirkle JL, "Exposure of the US population to environmental tobacco smoke: the Third National Health and Nutrition Examination Survey, 1988 to 1991" 275 : 1233-1240, 1996

26 Pacifici R, "Environmental tobacco smoke: nicotine and cotinine concentration in semen" 68 : 69-72, 1995

27 Jarvis MJ, "Elimination of cotinine from body fluids: implications for noninvasive measurement of tobacco smoke exposure" 78 : 696-698, 1988

28 Kuo HW, "Determination of urinary and salivary cotinine using gas and liquid chromatography and enzyme-linked immunosorbent assay" 768 : 297-303, 2002

29 Zevin S, "Cotinine effects on nicotine metabolism" 61 : 649-654, 1997

30 Jarvis MJ, "Comparison of tests used to distinguish smokers from nonsmokers" 77 : 1435-1438, 1987

31 Bramer SL, "Clinical considerations in study designs that use cotinine as a biomarker" 8 : 187-203, 2003

32 Murphy SE, "Characterization of multiple products of cytochrome P450 2A6-catalyzed cotinine metabolism" 12 : 639-645, 1999

33 Alshaarawy O, "Association of serum cotinine levels and hypertension in never smokers" 61 : 304-308, 2013

34 Wei B, "Assessing exposure to tobacco-specific carcinogen NNK using its urinary metabolite NNAL measured in US population: 2011-2012" 26 : 249-256, 2016

35 Jemal A, "Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control" 100 : 1672-1694, 2008